Baird lowered its price target on Axovant Sciences (NASDAQ: AXON) to $2.00 (from $6.00) while maintaining a Neutral rating, saying ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE